Sugarland, TX, United States of America

Raymond G Fenwick

This inventor holds 1 USPTO granted patent. Top assignee: Baylor College of Medicine. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Raymond G. Fenwick

Introduction

Raymond G. Fenwick is a notable inventor based in Sugarland, TX (US). He has made significant contributions to the field of genetics, particularly in the diagnosis of myotonic muscular dystrophy. His work has implications for understanding and detecting this genetic disorder, which affects muscle function.

Latest Patents

Fenwick holds a patent for the "Diagnosis of myotonic muscular dystrophy." This invention includes a DNA clone from the myotonic muscular dystrophy gene and a cosmid probe to the myotonic dystrophy site. The methods described in the patent involve detecting myotonic muscular dystrophy using restriction fragment length polymorphism (RFLP). The process includes digesting DNA from an individual with a restriction endonuclease and detecting the resulting fragments through hybridization and southern blot analysis. Additionally, the gene can be measured by assessing mRNA levels or protein amounts using antibodies. The patent also outlines methods for detecting the gene defect using fluorescence in situ hybridization or pulsed field gel electrophoresis.

Career Highlights

Fenwick is affiliated with Baylor College of Medicine, where he continues to contribute to research and innovation in genetics. His work has been instrumental in advancing the understanding of myotonic muscular dystrophy and its genetic underpinnings.

Collaborations

Fenwick has collaborated with notable researchers such as Ying-Hui Fu and Antonio Pizzuti. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Raymond G. Fenwick's contributions to the diagnosis of myotonic muscular dystrophy highlight the importance of innovation in genetics. His patent and ongoing work at Baylor College of Medicine continue to pave the way for advancements in understanding and treating this condition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…